Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Revance Supports Acne Awareness Month with SkinPen and PanOxyl Partnership Campaign

Revance Therapeutics, Inc. (PRNewsfoto/Crown Laboratories, Inc.)

News provided by

Revance

Jun 01, 2026, 09:00 ET

Share this article

Share toX

Share this article

Share toX

The brands unite to support consumers through every stage of the acne journey, from active breakouts to the appearance of post-acne scarring

NASHVILLE, Tenn., June 1, 2026 /PRNewswire/ -- This Acne Awareness Month, SkinPen and PanOxyl are joining forces for a new campaign spotlighting a holistic approach to acne care. Together, the brands are showcasing how consumers can address both active acne and the lasting effects of the appearance of facial acne scars through a comprehensive skincare journey.

The partnership highlights the strength of the Revance portfolio and its ability to support consumers across every stage of the acne experience. As PanOxyl targets existing acne while helping prevent future breakouts with trusted formulas featuring benzoyl peroxide, salicylic acid, adapalene, and sulfur, SkinPen improves the appearance of facial acne scars by stimulating natural skin regeneration to refresh and reveal healthier-looking skin.1

Rooted in more than 50 years of heritage, PanOxyl is the #1 Dermatologist-recommended benzoyl peroxide brand.* Its diverse portfolio includes award-winning skincare products designed to help consumers manage their acne, including the #1 best-selling acne wash in the US.**

"Acne can have a significant emotional impact on confidence at every age and stage of life," said Steve Gallopo, EVP & Chief Commercial Officer of Consumer Skincare for Crown Laboratories, Inc., a Revance Company. "This campaign is about helping consumers feel supported throughout their skincare journey and empowering them with trusted solutions from PanOxyl that help them put their best face forward."

SkinPen is the #1 brand in microneedling pens in the U.S., chosen by providers and patients alike for its approach to the appearance of facial acne scars.2† Designed to support the skin's natural regenerative process, SkinPen helps improve the appearance of facial acne scars across all skin types, any time of year.3‡

"With SkinPen, we are committed to advancing innovative solutions that address the lasting visible effects of acne," said Curry Smith, Executive Marketing Director of Regenerative Aesthetics at Revance. "Our technology is built to support providers and patients with a reliable, year-round option that fits seamlessly into a comprehensive approach to facial acne scar care."

As part of the campaign, the brands are partnering with board-certified plastic surgeon Dr. Michelle Lee and influencer Bridget Campbell to share both personal and professional perspectives on acne and acne scar care. Through firsthand storytelling and expert-led educational content, the partnerships aim to foster greater awareness around acne, treatment options, and long-term skin outcomes.

In support of the initiative, Revance will also host an intimate media deskside session with Dr. Suneel Chilukuri, Board-Certified Dermatologist and Cosmetic Surgeon and top beauty and health editors to further explore the SkinPen and PanOxyl partnership, discuss the evolving acne conversation, and educate attendees on options for both active acne and facial acne scarring.

"Acne is a journey that extends beyond active breakouts, often leaving behind visible reminders long after acne has cleared," said Dr. Suneel Chilukuri. "By pairing PanOxyl's trusted acne care options with SkinPen's approach to improving the appearance of facial acne scars, we're able to support patients through multiple stages of their skincare journey with complementary solutions that address both treatment and recovery."

As part of Acne Awareness Month, SkinPen is spotlighting its ongoing "$100 Reasons to Love SkinPen" rebate program, offering eligible patients a $100 rebate with the purchase of a series of three or more SkinPen® treatments through 6/30. In tandem, PanOxyl is introducing its first-ever Amazon promotion with 20% off any item for the month of June, further expanding access to trusted acne products for consumers throughout the campaign period.†*

For more information on SkinPen and PanOxyl, please visit their respective websites.

SkinPen Rebate Terms and Conditions:
Open to U.S. residents, age 22+. Begins on 2/1/26 and ends 11:59 PM PT on 6/30/26. Claims must be received by 7/7/26. Valid with purchase of 3+ SkinPen treatments at an authorized provider. Limit one rebate per person. $100 rebate will be awarded as a prep-paid digital gift card. Void where prohibited. Sponsor: Revance Therapeutics, Inc. For complete details, visit Sweepstakes.SkinPen.com.

*IQVIA, May 2024

**Source: Circana, LLC, Total US – MULO+, Acne Treatment, Form: Wash, Dollar & Unit Sales, 52 WE Dec 28, 2025

†Data on file. Gordian Solutions Group, 2025 Market Survey. Question: "Of your patients per month that you treat with microneedling pens, how many are treated with each of the pens below?" N=99.

‡For SkinPen, avoid sun exposure 24 hours prior and 72 hours post-treatment

†*Do not use PanOxyl within 24 hours after SkinPen treatment.

IMPORTANT SAFETY INFORMATION
SkinPen Precision and SkinPen Precision Elite are microneedling devices and accessories intended to be used as a treatment to improve the appearance of facial acne scars in adults with all Fitzpatrick skin types and wrinkles of the neck for Fitzpatrick skin types II - IV aged 22 years and older.

This treatment is not for everyone. Common post-treatment responses include temporary redness, tenderness, itchiness, dryness, and peeling. Talk to your provider to learn more about whether SkinPen is right for you.

References:

  1. 2021 Wamsley MN FLAW (2021 FLAW), P14A
  2. Gordian Solutions Group, 2025 SkinPen, Market Survey, Slide 21
  3. SkinPen® Precision System De Novo Summary (DEN160029), p21A

PanOxyl® is a registered trademark of Crown Laboratories, Inc., a Revance company.
SkinPen® Precision™ and SkinPen® Precision Elite™ are trademarks of Bellus Medical, LLC, a Revance company.

SOURCE Revance

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Revance Distributed Over 1 Million SkinPen® Treatment Kits to Customers Since January 2025

Revance Distributed Over 1 Million SkinPen® Treatment Kits to Customers Since January 2025

Revance, a fast-growing global aesthetics and skincare company, announced today that it has distributed over one million SkinPen treatment kits...

Revance Presents Award-Winning Aesthetics and Skincare Portfolio at 2026 AAD Annual Meeting

Revance Presents Award-Winning Aesthetics and Skincare Portfolio at 2026 AAD Annual Meeting

Revance, a fast-growing global aesthetics, regenerative and consumer skincare company, will showcase the latest innovations and new indications...

More Releases From This Source

Explore

Advertising

Advertising

Retail

Retail

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Cosmetics and Personal Care

Cosmetics and Personal Care

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.